Cargando…

Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma

BACKGROUND: Ampullary adenocarcinoma is a rare gastrointestinal cancer associated with diverse outcomes due to clinical and pathological heterogeneity. Standardized methods to better prognosticate and inform therapeutic selection for ampullary adenocarcinoma are needed. This study explored the novel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Overman, Michael J., Soifer, Harris S., Schueneman, Aaron Joel, Ensor, Joe, Adsay, Volkan, Saka, Burcu, Neishaboori, Nastaran, Wolff, Robert A., Wang, Huamin, Schnabel, Catherine A., Varadhachary, Gauri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994309/ https://www.ncbi.nlm.nih.gov/pubmed/27549176 http://dx.doi.org/10.1186/s12885-016-2677-3

Ejemplares similares

Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma
por: Schueneman, A, et al.
Publicado: (2015)

Defining a Distinct Immunotherapy Eligible Subset of Patients with Cancer of Unknown Primary Using Gene Expression Profiling with the 92‐Gene Assay
por: Raghav, Kanwal, et al.
Publicado: (2020)

Gene Expression Profiling of Ampullary Carcinomas Classifies Ampullary Carcinomas into Biliary-Like and Intestinal-Like Subtypes That Are Prognostic of Outcome
por: Overman, Michael J., et al.
Publicado: (2013)

Correction: Gene Expression Profiling of Ampullary Carcinomas Classifies Ampullary Carcinomas into Biliary-Like and Intestinal-Like Subtypes That Are Prognostic of Outcome
por: Overman, Michael J., et al.
Publicado: (2013)

Pathologic Evaluation of Endoscopically Resected Non-Ampullary Duodenal Lesions: A Single Center Experience
por: Taşkın, Orhun Çığ, et al.
Publicado: (2020)

Phase II Study of Panitumumab in RAS Wild‐Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater
por: Gulhati, Pat, et al.
Publicado: (2017)

Chinese Ischemic Stroke Subclassification
por: Gao, S., et al.
Publicado: (2011)

The Evolution of Ovarian Carcinoma Subclassification
por: Köbel, Martin, et al.
Publicado: (2022)

Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes
por: Raghav, Kanwal, et al.
Publicado: (2016)

Diagnosis and Subclassification of Acute Lymphoblastic Leukemia
por: Chiaretti, Sabina, et al.
Publicado: (2014)

Interphysician agreement on subclassification of myocardial infarction
por: Gard, Anton, et al.
Publicado: (2018)

OTHR-16. MOLECULAR PROFILING USING THE 92-GENE ASSAY FOR TUMOR CLASSIFICATION OF BRAIN METASTASES
por: Brenner, Andrew, et al.
Publicado: (2019)

Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma
por: Raghav, Kanwal, et al.
Publicado: (2021)

The symptomatic localization-related epilepsies: problems with subclassification.
por: Williamson, P. D.
Publicado: (1987)

Pathobiological and Radiological Approach For Hepatocellular Carcinoma Subclassification
por: Vasuri, Francesco, et al.
Publicado: (2019)

Proposal of a T3 Subclassification for Colon Carcinoma
por: Merkel, Susanne, et al.
Publicado: (2022)

Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples
por: Brachtel, Elena F., et al.
Publicado: (2016)

Is Preoperative Subclassification of Type I Choledochal Cyst Necessary?
por: Jung, Kyuwhan, et al.
Publicado: (2012)

Subclassification of Newly Diagnosed Glioblastomas through an Immunohistochemical Approach
por: Conroy, Siobhan, et al.
Publicado: (2014)

Evolution and current status of the subclassification of intermediate hepatocellular carcinoma
por: Yi, Peng-Sheng, et al.
Publicado: (2020)

The role of pyroptosis-related genes in the diagnosis and subclassification of sepsis
por: Ding, Wencong, et al.
Publicado: (2023)

Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma
por: Abdel-Wahab, Reham, et al.
Publicado: (2018)

Eosinophilic Cholecystitis and Eosinophils in Gallbladder Injuries: A Clinicopathological Analysis of 1050 Cholecystectomies
por: Memis, Bahar, et al.
Publicado: (2023)

Divide and conquer: the genetic basis of molecular subclassification of breast cancer
por: Kristensen, Vessela N
Publicado: (2011)

Gene content dissimilarity for subclassification of highly similar microbial strains
por: Tu, Qichao, et al.
Publicado: (2016)

Do the Data Support Manometric Subclassifications for Ineffective Esophageal Motility?
por: Singhal, Saurabh, et al.
Publicado: (2017)

Usefulness of subclassification of adult diabetes mellitus among inpatients in Japan
por: Saito, Kohei, et al.
Publicado: (2021)

Incorporating circulating cytokines into the idiopathic inflammatory myopathy subclassification toolkit
por: De Paepe, Boel
Publicado: (2023)

MDS subclassification—do we still have to count blasts?
por: Huber, Sandra, et al.
Publicado: (2023)

Precision subclassification of type 2 diabetes: a systematic review
por: Misra, Shivani, et al.
Publicado: (2023)

Challenges in the Study of Adjuvant Chemoradiation After Pancreaticoduodenectomy
por: Crane, Christopher H., et al.
Publicado: (2009)

Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction
por: Chouhan, Jay, et al.
Publicado: (2015)

Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait
por: Huey, Ryan W., et al.
Publicado: (2019)

Cancer of Unknown Primary Presenting as Bone‐Predominant or Lymph Node‐Only Disease: A Clinicopathologic Portrait
por: Huey, Ryan W., et al.
Publicado: (2021)

Basal cell carcinoma with progression to metastatic neuroendocrine carcinoma
por: Patel, Raj, et al.
Publicado: (2010)

Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2008)

Effect of a Specific Questionnaire Sheet on Subclassification of Osteonecrosis of the Femoral Head
por: Hatanaka, Hiroyuki, et al.
Publicado: (2020)

Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits
por: Li, Mei-Mei, et al.
Publicado: (2021)

Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification
por: Yamamoto, Masateru, et al.
Publicado: (2021)

The Spectrum of HPV-independent Penile Intraepithelial Neoplasia: A Proposal for Subclassification
por: Regauer, Sigrid, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gvlckmg9fgpm7946mpqpvisnaf